NCT02484482
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Severance Hospital Seoul, Seodaemun-gu, South Korea
Clinical trial condition
Dyslipidemia
Explore clinical trials studying Dyslipidemia. Study availability and eligibility vary by location and protocol.
389 public trials
26 recruiting studies
Dyslipidemia trial results
NCT01893515
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Medical Affiliated Research Center, Inc. Huntsville, Alabama, United States
- Terence Hart, MD Muscle Shoals, Alabama, United States
- Central Phoenix Medical Clinic Phoenix, Arizona, United States
- Pacific Oaks Medical Group Beverly Hills, California, United States
Completed
Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039)
NCT01114490
- Conditions
- Digestive System Diseases, Dyslipidemia, Dyslipidemias, +5 more
- Locations
-
Not specified
NCT02541201
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
Not specified
NCT01112423
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Osborne Research Center Little Rock, Arkansas, United States
- Pra International Lenexa, Kansas, United States
- Sterling Research Grp, Ltd. Cincinnati, Ohio, United States
- Cetero Research - San Antonio San Antonio, Texas, United States
NCT01071291
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
Not specified
Completed
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT02156544
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Severance Hospital Seoul, Seodaemun-gu, South Korea
NCT02230345
- Conditions
- Dyslipidemia, Dyslipidemias, Inflammation, +5 more
- Locations
-
- Clinical research center, Lausanne University hospital Lausanne, Canton of Vaud, Switzerland
NCT00928694
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
Not specified
Completed
Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038)
NCT01122667
- Conditions
- Dyslipidemia, Dyslipidemias, Female Urogenital Diseases, +9 more
- Locations
-
Not specified